Pre-treatment Haemoglobin Concentration is a Prognostic Factor in Patients with Early-stage Breast Cancer

Author： Kandemir EG Mayadagli A Turken O Yaylaci M Ozturk A

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.33, Iss.3, 2005-05, pp. : 319-328

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quality-of-Life Considerations in the Treatment of Early-Stage Breast Cancer in the Elderly

By Reimer Toralf Gerber Bernd

Drugs & Aging, Vol. 27, Iss. 10, 2010-10 ,pp. : 791-800

Adis International

Access to resources Recommend Favorite

Trastuzumab in Early-Stage Breast Cancer: The Question of Treatment Timing

By Simoens Steven

PharmacoEconomics, Vol. 26, Iss. 10, 2008-01 ,pp. : 807-809

Adis International

Access to resources Recommend Favorite

Granulocyte-Colony Stimulating Factor Use and Medical Costs after Initial Adjuvant Chemotherapy in Older Patients with Early-Stage Breast Cancer

By Griffiths Robert I. Barron Richard L.

PharmacoEconomics, Vol. 30, Iss. 2, 2012-02 ,pp. : 103-118

Adis International

Access to resources Recommend Favorite

The Croatian government is to pay for early-stage human epidermal growth factor receptor 2-positive breast cancer patients to receive Roche's Herceptin

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 526, 2007-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Letrozole is an effective option in the treatment of early-stage or advanced breast cancer in postmenopausal women

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 21, Iss. 1, 2005-01 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite